Aarti Drugs Limited has announced the scheduling of its Quarterly Earnings Conference Call for investors and analysts. The call is set to take place on Wednesday, February 4, 2026, commencing at 11:00 AM IST. The purpose of this conference call is to discuss the company’s financial performance for the quarter and the nine months that concluded on December 31, 2025. The company has provided details for participation, including dial-in numbers for India, the United States, the United Kingdom, Singapore, and Hong Kong. The call will feature key management personnel, including Mr. Harshit Savla (Jt. Managing Director), Mr. Harit Shah (Whole time Director), Mr. Adhish Patil (Chief Finance Officer & Chief Operating Officer), and Mr. Vishwa Savla (Managing Director, Pinnacle Life Science Private Limited). An invitation with a pre-registration link and conference dial-in details has been attached. Strategic Growth Advisors Pvt. Ltd. has been designated for RSVPs, with contact persons Mr. Deven Dhruva and Ms. Krisha Shrimankar available for inquiries.
